ImmuCell Corporation Long-Term Debt, Maturity, Year Two
ImmuCell Corporation (ICCC) had Long-Term Debt, Maturity, Year Two of $1.24 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2025-11-13
- 2025-09-30: Long-Term Debt, Maturity, Year Two $1.24M.
- 2025-03-31: Long-Term Debt, Maturity, Year Two $798.81K.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2025-09-30 | $1.24M 10-Q · filed 2025-11-13 |
| 2025-03-31 | $798.81K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |